Good bet money for Kevetrin. Oct 22 2018 "The Company is in the process of selecting a Contract Research Organization to complete the necessary remaining bridging toxicology work toward developing Kevetrin in oral form, which remains the top priority within Innovation Pharmaceutical’s cancer program".
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links